These effects, along with a prior report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two assist the concept of targeting ACKR3 as a novel way to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked disorders.Morphine as well as other opioids enhance the action